5th WORLD PSORIASIS & PSORIATIC ARTHRITIS CONFERENCE 2018
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
The International Federation of Psoriasis Associations welcomes You to the
5th WORLD PSORIASIS & PSORIATIC ARTHRITIS
CONFERENCE 2018
“Psoriasis – Science and Patients: Global Challenges and Future perspectives.”
June 27 - 30, 2018
Stockholm Waterfront Congress Centre, Stockholm, Sweden
Conference Mission
IFPA World Conference
The World Psoriasis & Psoriatic Arthritis Conference is Delegates can explore the psoriasis disease from different
an established scientific conference organized by IFPA. It perspectives by networking with patients and industry rep-
presents the latest developments in psoriasis and psoriat- resentatives in attendance. Since 2006, we have organized
ic arthritis research. Because medical professionals from the World Conference every third year. The latest confer-
both the dermatology and rheumatology field attend, the ence drew over 1,000 delegates from across the world.
conference provides a unique cross-specialty forum.
Conference Objectives
Our aim with the World Psoriasis & Psoriatic Arthritis Conference is to:
• Increase global recognition of the psoriasis disease and its severity;
• Unite psoriasis stakeholders, to strengthen international collaboration;
• Share the latest scientific and clinical developments on psoriasis;
• Encourage new research projects;
• Highlight the patient perspective, so that the conference will ultimately improve living conditions for the international
psoriasis community.
The 5th World Psoriasis & Psoriatic Arthritis Conference will be held on June 27-30, 2018 in Stockholm, Sweden.
Its theme is “Psoriasis – Science and Patients: Global Challenges and Future perspectives.”
We look forward to seeing you in June 2018!
About IFPA
The International Federation of Psoriasis Associ- IFPA Vision
ations (IFPA) is a non profit organization made up
A world without human suffering from psoriasis
of psoriasis associations from around the world.
IFPA unites psoriasis associations so that their global cam-
IFPA Mission
paign for improved medical care, greater public under- To be the unifying global voice of all psoriasis associations,
standing and increased research will improve the lives of supporting, strengthening and promoting their cause at an
people who live with psoriasis and psoriatic arthritis. international level
Worldwide unity for people living with psoriasis For more information about IFPA and our activities,
please visit
IFPA gives nonprofit psoriasis associations a global voice to www.ifpa-pso.org and www.worldpsoriasisday.com.
campaign on behalf of people who have psoriasis and psori-
atic arthritis. IFPA provides the unity that strengthens ev-
eryone’s ability to support research that will someday find a
cause and a cure for these diseases.
Welcome to the
5th World Psoriasis & Psoriatic Arthritis Conference
Dear Friends, Dear Colleagues and Friends,
During the past decade, we’ve seen a rapid expansion of In 2018, Stockholm will once again welcome delegates
our psoriasis knowledge and tremendous improvements from all over the world, for a few intense days of pso-
in treatment methods. Better than ever, we understand riasis discussions at the 5th World Psoriasis & Psoriatic
the complexity of the disease and the way its comorbid- Arthritis Conference.
ities can affect people on multiple levels.
During the first conference in 2006, it seemed inno-
That is why the World Psoriasis & Psoriatic Arthritis vative (and perhaps even controversial) to organize a
Conference is among IFPA’s most important activities. conference with rheumatologists and dermatologists
We organize this conference to stimulate this knowl- attending side-by-side. Since then, this setup has been
edge expansion through discussions between experts. widely accepted and embraced. Since then, the ambition
Every third year, the Conference gathers dermatolo- of the conference has grown, so that today’s aim is to re-
gists, rheumatologists and allied healthcare profession- flect the entire spectrum of psoriasis, including associat-
als and allows them to share their most recent insights. ed manifestations.
The patient perspective is also reflected at each Confer-
ence, as IFPA’s national member associations put for- Over the past decade, we have witnessed tremendous
ward issues they believe are important to highlight on progress in our understanding of the disease. Thera-
the Conference agenda. peutic strategies have developed rapidly and our treat-
ment toolbox has been refined. This means precision
To ensure that each Conference results in tangible medicine and tailored treatment appear within reach:
achievements for the psoriasis community, we always ever more patients can enjoy better disease control. But
strive to incorporate the Conference’s conclusions in still, gaps remain and new questions arise. The more we
our work. Past Conferences have for example success- learn about psoriasis, the clearer we see how complex
fully affected our global advocacy work, by providing in- the disease is. That is why we must continue educating
put to our lobbying efforts at the World Health Organi- ourselves as we go along.
zation. This resulted in the WHO adopting a Resolution
on Psoriasis in 2014 and publishing a Global Report on At the upcoming conference, we will discuss the latest
Psoriasis two years later. Our next advocacy challenge psoriasis insights and developments. The program will
is firmly placing psoriasis on the international non-com- be shaped with some valuable suggestions from IFPA
municable disease agenda, next to related NCDs like members in mind. They highlighted areas of concern for
diabetes or cardiovascular disease. It will be interesting patients – including treatment, safety and access. Re-
to incorporate the upcoming Conference’s conclusions viewing the pros and cons of using biologics was also a
in this project. suggested program item. The topic wish list is long – but
this only means exciting discussions await us!
We already look forward to meeting you, engaging in
stimulating discussions and together getting one step We look forward to seeing you in a summery Stockholm
closer to a world free from psoriasis suffering. in 2018,
Welcome to Stockholm and the IFPA World Conference Prof. Mona Ståhle
2018 – President of the Conference
Lars Ettarp Dr. Arthur Kavanaugh
President and Prof. Peter van de Kerkhof
International Federation of Psoriasis Associations Co-Chairmen, Scientific Executive Committee
Committees
Scientific Executive Committee Scientific Program Committee
President of the Conference Prof. Mona Ståhle Ade Adebajo (UK)
Co-Chairman Dr. Arthur Kavanaugh Philip Helliwell (UK)
Co-Chairman Prof. Peter van de Kerkhof Abrar Qureshi (US)
Secretary Barbra Bohannan Jonathan Barker (UK)
Elaine Husni (US)
Kristian Reich (Germany)
Complementary Program Committee Anthony Bewley (UK)
Alexa Kimball (USA)
Chairman: Dr. Hoseah Waweru Ricardo Romiti (Brazil)
Laura Coates (UK)
Gerald G. Krueger (US)
Caitriona Ryan (US)
IFPA Scientific Advisory Board Gladys Léon Dorantes (Mexico)
Jo Lamberä-t (Belgium)
Mark Lebwohl (USA) Mahira El Sayed (Egypt)
Jörg Prinz (Germany) Kristina Callis Duffin (US)
Mona Ståhle (Sweden) Steven Loo (Hong Kong)
Philip Mease (USA) Evan Siegel (US)
Christopher Ritchlin (USA) Lorna Fernandez Frez (Philippines)
Peter van de Kerkhof (Netherlands) Nehal Mehta (US)
Alan Menter (USA) Lone Skov (Denmark)
Claire Fuller (UK)
Joseph Merola (US)
Organizing Committee Sergio Toloza (Argentina)
IFPA Board Paolo Gisondi (Italy)
IFPA Secretariat Ulrich Mrowietz (Germany)
Abby Van Voorhees (US)
Dafna Gladman (Canada)
Luigi Naldi (Italy)
Jianghong (Julie)
Yu (China/US)
Alice Gottlieb (US)
Sandra Navarra (Philippines)
Jie Zheng (China)
Contact information
Meetagain – Conference organizing bureau Address
International Federation of Psoriasis Associations
Do you have a practical question? IFPA Secretariat
Please contact the conference organizing bureau, Gustavslundsvägen 143
Meetagain. 167 51 Bromma, SWEDEN
Address info@ifpa-pso.com
Meetagain
Råsundavägen 13 Do you have a question about the conference’s content?
169 67 Solna, SWEDEN Do you want to comment on the scientific program, the
program committees or the conference’s official speakers?
Contact: Anki Frencken Please contact Barbra Bohannan, Secretary of the Scientif-
ic Executive Committee.
ifpaworldconference@meetagain.se
+46 (0)8 664 58 00 barbra.bohannan@gmail.com
IFPA – Conference organizer Social media
Do you have a general question? To get the latest news on psoriasis and the IFPA World
Do you want to know more about the organization behind Conference, visit our official Facebook page or our Twitter
the conference, the conference’s history or how patients page.
can get involved? Please contact the conference organizer,
IFPA.
Scientific Program Preliminary program, may be subject to change
28TH OF JUNE - THURSDAY
Time Symposium
07.15-08.00 Satellite symposium
07.30 Registration opens
08.15-08.35 Opening ceremony
08.35-10.00 Immunology
- Frontiers in psoriasis research: new findings and potential long-term suppression
- Immunological principles in psoriasis and psoriatic arthritis
- Therapeutic targets in psoriasis and psoriatic arthritis
- Discussion
10.00-10.30 Coffee/Posters/Exhibits
10.30-11.10 A personalized approach in the treatment of psoriasis and psoriatic arthritis
11.10-12.00 Interactive session with two case presentations
12.00-13.30 Lunch/Posters/Exhibits
12.15-13.15 Satellite symposium
13.30-15.10 Psoriasis and psoriatic arthritis treatment and care around the world
- Africa
- AsiaPacific
- Middle East
- Latin America
15.10-15.30 Oral abstract presentations
15.30-16.00 Coffee/Posters/Exhibits
16.00-16.40 The Global Psoriasis Atlas: a tool to address unmet needs in psoriasis
17.00-18.00 Satellite Symposium
29TH OF JUNE - FRIDAY
Time Symposium
07.30-08.30 Posters/Exhibits
07.30-08.15 Satellite symposium
08.30-09.40 Diagnostics – biomarkers and clinical indicators:
- Biomarkers
- Early detection of psoriatic arthritis in psoriasis patients
- Screening for comorbidities
- Discussion
09.40-10.00 Oral abstract presentations
10.00–10.30 Coffee/Posters/Exhibits
10.30–12.00 Challenges in disease management:
- Pain management in psoriatic arthritis
- Management of psoriasis/psoriatic arthritis before, during and after pregnancy
- Management of psoriasis/psoriatic arthritis in the pediatric population
- Presentation of a challenging case
- Discussion
Program continued on next page
Scientific Program Preliminary program, may be subject to change
29TH OF JUNE - FRIDAY
Time Symposium
12.00–13.30 Lunch/Posters/Exhibits
12.15–13.15 Satellite symposium
13.30-15.30 Treatment guidelines and outcomes measures:
- Current treatment guidelines for psoriasis and psoriatic arthritis
- Outcomes measures in psoriasis and psoriatic arthritis – a comprehensive review
- The ideal treatment – what is it and is it possible to attain?
15.30 - 16.00 Coffee/Posters/Exhibits
16.00–16.40 The virtual doctor: Working in a virtual treatment environment
17.00-18.00 Satellite Symposium
30TH OF JUNE - SATURDAY
Time Symposium
07.30-08.30 Coffee/Posters/Exhibits
08.30–09.40 Treatment session
Management of low-to-moderate psoriasis
The gut-joint axis in psoriatic arthritis
New to market - an overview
09.40-10.00 Oral abstract presentations
Novel therapeutic targets in psoriasis and psoriatic arthritis
The role of gonadotropin in autoimmune diseases
10.00 – 10.30 Coffee/Posters/Exhibits
10.30-11.10 15 years of biologic treatment of psoriasis and psoriatic arthritis
– long-term efficacy and safety
11.10 – 12.00 Biosimilars
- How original is the original?
- Recommendations for usage of biosimilars
- Discussion
12.00–13.30 Lunch/Posters/Exhibits
12.15-13.15 Satellite symposium
13.30-14.40 Comorbidities
- Overview – what do we know today
- Psoriasis and the gut
- Pso/PsA and cardiovascular disease – fact and fiction
- Pso/PsA and the brain
- Discussion
14.40-15.00 Interactive session with interesting clinical case – management of comorbidities
15.00-15.30 Coffee/posters/exhibits
15.30–16.10 Is an integrated psoriasis care possible – or just an utopian patient dream?
16.10-16.30 The Global Psoriasis Coalition and the way forward
16.30-16.45 Closing of scientific program
Kindly check www.ifpaworldconference.com for more information about
the program, the registration and other practical information.
Key dates to remember
October 1st 2017 Online registration opens
Mid-December 2017 Abstract submission opens
March 2018 Early registration deadline
June 2018 On-site registration opens at the conference venue
The 5th IFPA World Psoriasis & Psoriatic Arthritis Conference is made
possible thanks to generous support from our partners
We thank Celgene, Lilly and Sun Pharma for supporting the IFPA’s World
Conference, marketing and promotion
Jeppe Wikstrom/mediabank.visitstockholm.comThe 5th World Psoriasis & Psoriatic
Arthritis Conference 2018 is presented
by the International Federation of
Psoriasis Associations, IFPA
WORLDWIDE UNITY
FOR PEOPLE LIVING WITH
PSORIASIS
www.ifpa-pso.orgYou can also read
